Profile data is unavailable for this security.
About the company
Shanghai Pharmaceuticals Holding Co Ltd is a China-based company principally engaged in pharmaceutical industry, distribution and retail business. The Company's products include innovative drugs, chemical drugs, traditional Chinese medicines and rare disease drugs. The Company's products are mainly used in the cardiovascular system, digestive tract and metabolism, systemic anti-infection, central nervous system, anti-tumor and immunomodulators, musculoskeletal system and respiratory system. In addition, the Company also provides medical logistics and warehousing services. The Company distributes its products both in the domestic market and to overseas markets.
- Revenue in CNY (TTM)264.22bn
- Net income in CNY3.79bn
- Incorporated1994
- Employees48.16k
- LocationShanghai Pharmaceuticals Holding Co LtdShanghai Pharmaceutical MansionNo.200 Taicang RoadSHANGHAI 200020ChinaCHN
- Phone+86 2 163730908
- Fax+86 2 163289333
- Websitehttps://www.sphchina.com/index/
More ▼
6.00%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| E Fund Management Co., Ltd.as of 31 Dec 2023 | 20.62m | 1.07% |
| GF Fund Management Co., Ltd.as of 31 Dec 2023 | 20.07m | 1.04% |
| China Universal Asset Management Co., Ltd.as of 31 Dec 2023 | 13.33m | 0.69% |
| ICBC Credit Suisse Asset Management Co., Ltd.as of 31 Dec 2023 | 13.01m | 0.68% |
| Yinhua Fund Management Co., Ltd.as of 30 Jun 2023 | 11.60m | 0.60% |
| Huatai-PineBridge Fund Management Co., Ltd.as of 31 Dec 2023 | 9.05m | 0.47% |
| Norges Bank Investment Managementas of 31 Dec 2023 | 8.40m | 0.44% |
| Lion Fund Management Co., Ltd.as of 31 Dec 2023 | 7.56m | 0.39% |
| The Vanguard Group, Inc.as of 04 Jul 2024 | 6.59m | 0.34% |
| BlackRock Fund Advisorsas of 04 Jul 2024 | 5.37m | 0.28% |
More ▼
Data from 31 Dec 2023 - 30 Jun 2024Source: FactSet Research Systems Inc.
